Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons Worl... (/p The Potential for EXPAREL ...)

HOME >> MEDICINE >> TECHNOLOGY

Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress

Date:12/6/2008

/p>

The Potential for EXPAREL

EXPAREL is a novel formulation of bupivacaine designed to provide effective, safe, prolonged (72 hours) postoperative pain relief in a single administration. Currently available local anesthetics typically have short (about 6 to 8 hours) duration of action resulting in limited pain relief in the first few days following surgery when pain is the most intense.

"The results of this study clearly demonstrate the potential of EXPAREL in fulfilling this unmet need," said Ronald Burch, M.D, PhD, Chief Medical Officer, Pacira. "EXPAREL represents an important advance in pain control that allows for extended delivery of bupivacaine, a well-characterized analgesic with a long-established efficacy and safety record. We look forward to sharing the results of multiple phase II and III clinical trials across a broad range of surgical procedures."

EXPAREL, currently in late Phase III clinical development, is being studied in several different types of surgical procedures where postoperative pain management is especially problematic. It is the latest product to benefit from Pacira Pharmaceutical's proprietary sustained-release DepoFoam(R) technology. DepoFoam technology is designed to address the limitations of widely known and used drugs by enhancing their dosing and/or administration profile. It achieves this by encapsulating the drug in multivesicular liposomal particles which then release the drug over a desired period of time without altering the drug molecule. DepoFoam is a proven technology that is already used in two commercially available products in the U.S. and Europe.

About Pacira

Pacira Pharmaceuticals, Inc. is an acute care specialty pharmaceutical company founded in March, 2007 through the acquisition of the former SkyePharma PLC injectable business, for which an experienced management team was assembled to address the needs of
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
2. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
3. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
4. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
5. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
6. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
9. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
10. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
11. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer

Post Your Comments:

(Date:12/15/2009)... 15 Immucor, Inc. (Nasdaq: BLUD ), ... the blood transfusion industry, today announced that it will ... January 6, 2010 after the market close. The Company ... 2010 at 8:30 a.m. (Eastern Time) to discuss the ... in this conference call by dialing 1-888-324-9321 (Passcode: BLUD). ...

(Date:12/15/2009)... -- Champions Biotechnology, Inc . (OTC Bulletin ... of advanced preclinical platforms and tumor specific data ... announced its financial results for the second fiscal ... of Company,s financial results are available in the ... Total revenues for the second quarter of 2010 ...

(Date:12/15/2009)... SRI International, an independent nonprofit research and development ... 7,592,021 for a new bioadhesive drug delivery system ... human body,s mucous membranes. This needle-free option uses ... much longer release time compared to alternatives such ... an effective means to introduce drugs across the ...

Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4 Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5 SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2 SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3 SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4 SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5 Nielsen Announces First Ever CLIO Healthcare Awards Now Accepting Entries 50537 1 Nielsen Announces First Ever CLIO Healthcare Awards Now Accepting Entries 50537 2 Nielsen Announces First Ever CLIO Healthcare Awards Now Accepting Entries 50537 3 Siblings target of intervention program 50533 1 Colorectal cancer 9090 1

[0] Immucor to Announce Fiscal Second Quarter Financial Results on Wednesday, January 6, 2010 [0] Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results [0] SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System

... 20% Reduction in the Risk, of Death at Six ... Five Years, ... N.J., May 28 Sanofi-aventis U.S.,announced today that the U.S. ... (sNDA) to include six-year overall,survival analysis from the MOSAIC trial ...

... study performed solely in high risk node-negative, ... Free Survival (DFS), BRIDGEWATER, N.J., May ... Investigacion en Cancer de Mama) announced today,that ... breast cancer,adjuvant treatment (post surgery) with Taxotere(R) ...

Other Medicine Technology:New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2 New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3 New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4 Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 2 Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 3 Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 4 Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy 5

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy

(Date:12/15/2009)... SALT LAKE CITY, Dec. 15 The new ... and Fitness ( www.LifeSpanFitness.com ), was highly ... the best treadmills for 2010. The compact TR200 folding ... Design, and Best Treadmill under $1000. ,, The ... walking indoors in small workout spaces. "This category buster ...

(Date:12/15/2009)... Force Operations Lead to Indictment of 30 Individuals ... than $61 Million in Fraudulent Billing to Medicare ... Thirty people have been charged in three cities ... more than $61 million in false Medicare claims ... Medicare Fraud Strike Force, Department of Health and ...

(Date:12/15/2009)... chronic obstructive pulmonary disease, or COPD, with increased activity ... body,s immune system. , The University of Michigan ... the immune system,s role in COPD, a serious, progressive ... with wheezing, shortness of breath, chest tightening and other ... to find better ways to detect and treat the ...

(Date:12/15/2009)... United Nations Foundation has led the fight against malaria, ... Report 2009 that the global strategies for ending malaria deaths are ... the United Nations Foundation , ... Washington, D.C. (Vocus) ... Nations Foundation has led the fight against malaria, and I ...

(Date:12/15/2009)... increases risk in teens, study suggests , , TUESDAY, Dec. ... obese increases the risk of obstructive sleep apnea, but ... younger children, Australian researchers have found. , In sleep ... 18, who were referred for evaluation of snoring and ... those aged 12 and older the risk of obstructive ...

Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4 Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5 Health News:Immune cell activity linked to worsening COPD 2 Health News:Immune cell activity linked to worsening COPD 3 Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2 Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2

[0] Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill [1] Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La.[1] Immune cell activity linked to worsening COPD [0] Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 [0] Puberty May Trigger Sleep Apnea in Overweight Kids

... investigating abnormal cell proliferation, a team led by scientists at ... intricate series of biochemical steps that shed light on a ... the latest in a long and distinguished line of research ... the common cold in people, but whose genome contains known ...

... may not cause bruises or black eyes, but the ... linger into early adulthood, a new University of Florida ... college students, UF researchers discovered a link between what ... anxiety in early adulthood, according to findings published online ...

... Federal ... Regulation, ... the availability of DRA Tool(TM), a new feature of its,Sentinel RCM(TM) ... editing module that comprehensively supports the,additional reporting requirements of Section 6002 ...

... but rural areas suffer as students choose specialty fields , , ... the number of general surgeons per 100,000 people in the ... a study by researchers at the University of Washington, Seattle. ... Medical Association,s Physician Masterfiles from 1981, 1991, 2001 and ...

... Select Medical,Corporation, a leading provider of specialty health ... million gift to Harrisburg,University of Science and Technology., ... by a corporation in,the six-year history of the ... Conference Center in the University,s new 16-story,Academic Center ...

... long been one of the worlds great killers. Now, ... occurring at an ominous and accelerating rate. To help ... of Allergy and Infectious Diseases (NIAID), part of the ... XDR TB research agenda. , A summary of the ...

Other Medicine News:Health News:Scientists discover a mechanism that can send cells on the road to cancer 2 Health News:Scientists discover a mechanism that can send cells on the road to cancer 3 Health News:Social form of bullying linked to depression, anxiety in adults 2 Health News:Social form of bullying linked to depression, anxiety in adults 3 Health News:Sentry Data Systems Announces Deficit Reduction Act Compliance Tool 2 Health News:Number of U.S. General Surgeons in Decline 2 Health News:Select Medical Corporation Makes Historic Multi-Million Dollar Gift to Harrisburg University 2 Health News:Select Medical Corporation Makes Historic Multi-Million Dollar Gift to Harrisburg University 3 Health News:NIAID describes research priorities to fight drug-resistant tuberculosis 2

Scientists discover a mechanism that can send cells on the road to cancer Social form of bullying linked to depression, anxiety in adults Sentry Data Systems Announces Deficit Reduction Act Compliance Tool Number of U.S. General Surgeons in Decline Select Medical Corporation Makes Historic Multi-Million Dollar Gift to Harrisburg University NIAID describes research priorities to fight drug-resistant tuberculosis

For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 10.4 mm....

For use with E5381 600 Circling Band (40 style)....

Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....

Used with Double Tantalum Clip (250 style) E5381 852. Overall length: 7.0 mm....

Medicine Products:

Meridional Implant (106 Style)Single Tantalum Clip (50 Style)Silicone Strip (42 Style)Silicone Boat (260 Style)

Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons Worl...(/p The Potential for EXPAREL ...),Health